NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 522.42M
Enterprise Value 33.65M
Trailing P/E N/A
Forward P/E 1-1.69
PEG Ratio (5 yr expected) 10.02
Price/Sales (ttm)N/A
Price/Book (mrq)1.22
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.29

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Sep 30, 2018


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-36.64%
Return on Equity (ttm)-59.58%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -12.58M
Net Income Avi to Common (ttm)-11.6M
Diluted EPS (ttm)-1.3740
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.32M
Total Cash Per Share (mrq)1.73
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.67
Book Value Per Share (mrq)1.95

Cash Flow Statement

Operating Cash Flow (ttm)-11.15M
Levered Free Cash Flow (ttm)-6.41M

Trading Information

Stock Price History

Beta (3Y Monthly) 1.27
52-Week Change 3-42.67%
S&P500 52-Week Change 3-6.95%
52 Week High 38.6100
52 Week Low 31.5200
50-Day Moving Average 32.4167
200-Day Moving Average 34.3383

Share Statistics

Avg Vol (3 month) 328.07k
Avg Vol (10 day) 37.33k
Shares Outstanding 59.42M
Float 4.7M
% Held by Insiders 123.16%
% Held by Institutions 152.90%
Shares Short (Dec 31, 2018) 491.97k
Short Ratio (Dec 31, 2018) 41.9
Short % of Float (Dec 31, 2018) 41.65%
Short % of Shares Outstanding (Dec 31, 2018) 40.98%
Shares Short (prior month Nov 30, 2018) 4147.21k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 29/1
Last Split Date 3May 11, 2017